Reply to: No Evidence that Glucosylsphingosine Is a Biomarker for Parkinson Disease.
Surface M, Balwani M, Waters C, Haimovich A, Gan-Or Z, Marder KS, Hsieh T, Song L, Padmanabhan S, Hsieh F, Merchant KM, Alcalay RN.
Surface M, et al. Among authors: hsieh t, hsieh f.
Mov Disord. 2022 Mar;37(3):654. doi: 10.1002/mds.28936. Epub 2022 Jan 29.
Mov Disord. 2022.
PMID: 35092096
No abstract available.